Ítem
Acceso Abierto

Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus : A systematic review and meta-regression

Título de la revista
Autores
Mendoza-Pinto, C.
Rojas-Villarraga, A.
Molano González, Nicolás
Jimenez-Herrera, E.A.
De La Luz Leon-Vazquez, M.
Montiel-Jarquõn, A.
Garcõa-Carrasco, M.
Cervera, R.
Mendoza-Pinto, Claudia
Rojas-Villarraga, Adriana

Archivos
Fecha
2018

Directores

ISSN de la revista
Título del volumen
Editor

Buscar en:

Métricas alternativas

Resumen
Abstract
Background Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density (BMD) and vertebral fractures (VF) in patients with systemic lupus erythematosus (SLE). Therefore, the objectives of this systematic review and meta-regression were: 1) to compare BMD between SLE patients and healthy controls and 2) to evaluate the relationship between BMD and glucocorticoid therapy and VF in SLE patients. Methods and findings Articles were identified from electronic databases (PubMed, Embase, VHL, SciELO and the Cochrane Library). Prospective longitudinal and cross-sectional studies were considered for review. We evaluated the quality of the evidence included using the Oxford Centre for evidence- based medicine (EBM) Levels of Evidence. In total, 38 articles were identified and analyzed (3442 SLE cases and 6198 controls) in the analysis of BMD (9232 women and 408 men). There were significant differences in mean BMD between SLE patients and controls. BMD mean difference in cases/controls: -0.0566 95% CI (-0.071, -0.0439; p = > 0.0001). When only SLE patients were analyzed, the BMD did not significantly differ between patients who had or had not received glucocorticoid (GCT) therapy. 694 SLE patients were included in the analysis of VF (189 with VF vs. 505 without VF). Patients with VF had lower BMD than patients without VF (BMD mean difference without VF/with VF: 0.033 (95%CI: 0.006±0.060); p-value: 0.0156). Conclusions Patients with SLE had lower BMD than healthy controls. Moreover, SLE patients with VF had lower BMD than patients without VF. However, our data did not show that GCT therapy had an impact on BMD. © 2018 van den Berg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Palabras clave
Glucocorticoides , Densidad osea , Terapia con corticosteroides , Asociación de la enfermedad
Keywords
Glucocorticoid , Bone density , Corticosteroid therapy , Disease association , Evidence based medicine , Gender , Human , Medication therapy management , Review , Spine fracture , Systematic review , Systemic lupus erythematosus
Buscar en:
Colecciones